Risultati qualitativi e quantitativi del programma di Valutazione Esterna di Qualità (VEQ) “VEQ SARS-CoV-2 RNA” condotto dai laboratori in Lombardia nel 2021 = Qualitative and quantitative performance of SARS-CoV-2 nucleic acid detection tests: results from the 2021 External Quality Assessment in Lombardy
Articolo
Data di Pubblicazione:
2023
Citazione:
Risultati qualitativi e quantitativi del programma di Valutazione Esterna di Qualità
(VEQ) “VEQ SARS-CoV-2 RNA” condotto dai laboratori in Lombardia nel 2021 = Qualitative and quantitative performance of SARS-CoV-2 nucleic acid detection tests: results from the 2021 External Quality Assessment in Lombardy / L. Pellegrinelli, F. Pasotti, G. Liga, C. Galli, M. Rizzetto, S. DA MOLIN, G. Azzarrà, O. Livia Lungu, S. Greco, S. Binda, D. Cereda, M. Corradin, E. Pariani, S. Buoro. - In: BIOCHIMICA CLINICA. - ISSN 0393-0564. - (2023), pp. 1-7. [Epub ahead of print] [10.19186/BC_2023.042]
Abstract:
Introduction: to evaluate the qualitative test performance and inter-assay variations of SARS-CoV-2 nucleic acid detection
tests by analysing the results of the External Quality Assessment (EQA) programme carried out in Lombardy in 2021.
Methods: the 2021 EQA for SARS-CoV-2 molecular test programme consisted on testing of 12 exercise (12 samples
of cells culture supernatants): 5 were SARS-CoV-2-negative and 7 SARS-CoV-2-positive samples [3 had viral load
(VL) >5×103 copies/mL, 4 VL=1-5×103 copies/mL]. Participating laboratories provided qualitative (positive/negative)
and quantitative (Cycle threshold, Ct value) results for each molecular test in use. Qualitative test performance was
evaluated by positive/negative percent agreement (PPA/NPA); inter-assay variation of quantitative results was evaluated
by coefficient of variation (CV).
Results: 79 to 90 laboratories participated by using 199 to 231 systems, returning 2 623 qualitative/quantitative results.
PPA ranged between 99.5% and 100%, NPA between 69.9% and 100%. NPA range was 99.1-100% by ruling out the
“invalid” results (n=89). CV ranged between 11.6% and 13.5% (samples with VL=1-5×103 copies/mL) and between
10.8% and 14.2% (samples with high VL). The two most used systems gave the following results. System A (275 results)
and B (245 results): CV by viral target ranged between 2.4-3.8% and 6.4-9% (samples with VL=1-5×103copies/mL) and
between 2.8-4.2% and 7.3-11.9% (samples with high VL) respectively.
Discussion: within 2021 EQA for SARS-CoV-2 molecular test, PPA and NPA were above 99.1%. However, the inter-assay
variability among systems was notable and related both to viral load and to viral target detected by the test. This variability,
thought limited, needs to be carefully evaluated and continuously monitored within quality assurance programs.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Verifica Esterna di Qualità, SARS-CoV-2, diagnostica molecolare;
Elenco autori:
L. Pellegrinelli, F. Pasotti, G. Liga, C. Galli, M. Rizzetto, S. DA MOLIN, G. Azzarrà, O. Livia Lungu, S. Greco, S. Binda, D. Cereda, M. Corradin, E. Pariani, S. Buoro
Link alla scheda completa: